Cannabis and Hemp Industry Investment News
Results from the phase Ib study are expected during this September quarter. The cannabis-derived pain control drug candidate CPAT-01 is targeting cats...
The company's lead drug candidate is a cannabis-derived canine pain medication. The company listed on the ASX in October 2017 via IPO () is leveraged ...
The company has entered into a research services agreement Eurofins Animal Health Pty Ltd. The collaboration will seek to expand the development progr...
The company has entered a research agreement which includes funding under the Kick-Start initiative for SMEs. CannPal is developing therapeutics for a...
() founder and managing director Layton Mills speaks to Proactive Investors about the innovative pet pharmaceutical company, which operates in the med...
CannPal has identified an opportunity in the medical cannabis and health markets. CannPal is a pharmaceutical-focused animal health company () holds a...
CannPal is researching the benefits of medical cannabis for companion animals. CannPal is the only ASX-listed pure animal health company CannPal Anima...
The company listed on the ASX in October 2017 after raising $6M. Clinical trials planned for Q1 CY18. () has been granted an authorisation to possess ...
The new facility allows the Vancouver-based company to cultivate five times the amount of cannabis flower than was previously produced through its Alt...
The new partnership transforms the Vancouver-based company into a US multistate operator by establishing a local manufacturing presence for its Altern...
The company is transporting 26 plant varieties, including 5,000 cloned plants and 200 so-called mom plants, to the facility The new building consists ...
The company plans to expand its production area to 2,215 square feet from 483 square feet, doubling its distillate production capacity Once its cannab...
What are you searching for? view1933 Industries Inc. Inc () (OTCMKTS:TGIFF) CEO Chris Rebentisch tells Proactive Investors the company has completed t...
Also on the move were Canopy Growth, Namaste, True Leaf, Green Growth Brands and MariMed Shares of 1933 Industries were on the rise Wednesday after it...
The initial operating capacity is roughly 22,000 square feet, with the option to expand into an additional 18,000 The building consists of 15 bloom ro...
The company said it was pleased to report strong growth compared to its last quarter, driven by rising consumer demand for its AMA cannabis products i...
The firm has established a foothold in Nevada, with a new cultivation facility complete and hemp processing lab on deck Brayden Sutton is a refreshing...
CBD sales in the US could exceed $20 billion by 2024 Inc ()(OTCQX:TGIFF) said Monday said its premium Canna Hemp brand of CBD wellness products is now...
What are you searching for? view1933 Industries Inc. () President Ester Vigil sat down with Steve Darling from Proactive Investors Vancouver to discus...
Well-positioned to take advantage of the blossoming US cannabis market Has expanded in Nevada, with new cultivation facility and new hemp processing f...
